February 6, 2019

Biomarkers in Alzheimer’s Disease Diagnostics: Moving Toward Earlier Diagnosis

International Conference on Alzheimer’s & Parkinson’s Diseases 2021


Dr. Schulz presented on the use of emerging biomarkers to aid in the earlier diagnosis of Alzheimer’s disease. This 30-minute presentation discusses the potential ways in which biomarkers can be assessed before the symptoms of cognitive impairment become apparent. Dr. Paul E. Shulz is the Rick McCord Professor in Neurology, the Umphrey Family Professor of Neurodegenerative Disorders, the Director of the Memory Disorders and Dementia Clinic, and the Director of the Neuropsychiatry and Behavioral Neurology Fellowship at the McGovern Medical School of UT Health Houston.

Key Learning Objectives for Biogen’s ADPD 2021 Virtual Education Theater:

  • Enhance the awareness of the Alzheimer’s Disease continuum and the importance of early diagnosis
  • Examine the biologic markers for Alzheimer’s Disease
  • Understand the AD patient’s diagnostic journey based on current and future diagnostic tools

Disclosure: The speaker received honoraria from Biogen for participation in this virtual education theater.

Disclaimer: All of the information discussed is for informational purposes only; does not constitute medical advice; and is not intended to be a substitute for independent professional medical judgment, advice, diagnosis, or treatment.